Arias Intel (ASNT) 10-Q 14 Feb 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2017	Feb. 14, 2018
Document And Entity Information
Entity Registrant Name	Arias Intel Corp.
Entity Central Index Key	1,585,755
Document Type	10-Q
Document Period End Date	Dec. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		30,455,167
Trading Symbol	ASNT
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,018

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Mar. 31, 2017
CURRENT ASSETS
Cash and cash equivalents	$ 14,763
Total current assets	14,763
OTHER ASSETS
Convertible note receivable	100,000	100,000
Interest receivable	10,500	6,000
Intellectual property, net	1,694,977
Total other assets	1,805,477	106,000
TOTAL ASSETS	1,820,240	106,000
CURRENT LIABILITIES
Accounts payable and accrued expenses	303,720	211,723
Bank overdraft		771
Due to related party	10,717	20,725
Derivative liability	2,720,852
Warrant liability	2,482,719
Convertible notes payable, net of debit discount of $447,712 and $587,675 respectively	594,288	614,000
Notes payable, net of debt discount of $0 and $1,667, respectively	600,000	598,333
Total current liabilities	6,712,296	1,445,552
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value, 10,000,000 shares authorized, -0- and -0- shares issued and outstanding as of 12/31/2017 03/31/2017, respectively.
Common stock, $0.001 par value, 500,000,000 shares authorized, 30,455,167 and 24,666,182 shares issued and outstanding as of 12/31/2017 and 03/31/2017, respectively.	30,455	24,666
Additional paid-in capital	11,558,700	5,698,167
Common stock payable	76,000
Accumulated deficit	(16,557,211)	(7,062,385)
Total stockholders' deficit	(4,892,056)	(1,339,552)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,820,240	$ 106,000

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2017	Mar. 31, 2017
Statement of Financial Position [Abstract]
Convertible notes payable, debt discount	$ 447,712	$ 587,675
Notes payable, debt discount	$ 0	$ 1,667
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	30,455,167	24,666,182
Common stock, shares outstanding	30,455,167	24,666,182

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
REVENUES
OPERATING EXPENSES
General and administrative	692,486	301,201	3,992,576	2,317,285
General and administrative - Related Party	59,842	64,992	398,423	400,083
Research and development - Related Party		71,400	199,000	572,400
Total Operating Expenses	752,328	437,593	4,589,999	3,289,768
LOSS FROM OPERATIONS	(752,328)	(437,593)	(4,589,999)	(3,289,768)
OTHER INCOME/(EXPENSE)
Interest income	1,500	1,500	4,500	4,500
Interest expense	(308,546)	(39,700)	(679,983)	(91,325)
Loss on change in derivative and warrant liability	(1,672,467)		(4,229,344)
Total other income/(expense)	(1,979,513)	(38,200)	(4,904,827)	(86,825)
NET LOSS	$ (2,731,841)	$ (475,793)	$ (9,494,826)	$ (3,376,593)
BASIC AND DILUTED LOSS PER COMMON SHARE	$ (0.09)	$ (0.02)	$ (0.33)	$ (0.15)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED	30,326,520	23,223,187	28,406,108	22,036,635

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
OPERATING ACTIVITIES
Net loss	$ (9,494,826)	$ (3,376,593)
Adjustments to reconcile net loss to net cash used by operating activities:
Amortization	305,023
Stock issued for services and expenses	2,750,384	1,348,941
Stock issued for interest expense	9,439
Amortization of debt discount	575,014	13,333
Expenses incurred on the issuance of convertible notes payable	35,000
Increase in derivative and warrant liability	4,229,344
Changes in operating assets and liabilities
Increase in interest receivable, related party	(4,500)	(4,500)
Decrease in other receivables	1,667
Increase (Decrease) in accounts payable and accrued expenses	91,997	49,993
Decrease in related party payable	(10,008)
Net cash used in operating activities	(1,511,466)	(1,968,826)
INVESTING ACTIVITIES
Net cash used in investing
FINANCING ACTIVITIES
Bank overdraft	(771)
Proceeds from common stock issued for cash and common stock payable	588,500	896,000
Proceeds from convertible notes payable	1,183,500	438,000
Proceeds from notes payable		580,000
Repayments of convertible notes payable	(245,000)
Net cash provided by financing activities	1,526,229	1,914,000
NET INCREASE IN CASH	14,763	(54,826)
CASH AT BEGINNING OF PERIOD		54,901
CASH AT END OF PERIOD	14,763	75
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest	43,156	64,292
Income taxes
NON CASH INVESTING AND FINANCING ACTIVITIES
Debt discount		6,667
Common Stock Payable for Services	31,000
Non cash stock issued in advance for prepaid expense		18,750
Stock issued for settlement of notes and interest	603,438
Stock issued for intellectual property	$ 2,000,000

Nature of Business

Nature of Business	9 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	1. NATURE OF BUSINESS Arias Intel Corp. (the “Company”) is a digital media platform for tech, media and gaming, which includes mobile gaming, augmented reality, on-demand delivery, digital and social media, and e-commerce. The Company is an early stage company and . The Company plans to generate revenue primarily through in-app purchases, service fees, and cross-channel advertising. The Company was incorporated under the laws of the State of Nevada on February 27, 2013 as American Riding Tours, Inc. Effective July 22, 2016, the Company changed its name from “American Riding Tours, Inc.” to “First Harvest Corp.” Effective December 1, 2017, the Company changed its name from “First Harvest Corp.” to “Arias Intel Corp.” Prior to the reverse acquisition described below, the Company did not have any significant assets or operations. Financial Statements Presented On February 10, 2017 (the “Closing Date”), the Company entered into and closed an agreement and plan of merger and reorganization (the “Merger Agreement”), with CV Acquisition Corp., a wholly-owned subsidiary of the Company (“Acquisition Corp.”), and Cannavoices, Inc. (“Cannavoices”). Pursuant to the Merger Agreement, effective on the Closing Date (i) Acquisition Corp. merged with and into Cannavoices, such that Cannavoices, the surviving corporation, became a wholly-owned subsidiary of the Company, and (ii) the Company issued an aggregate of 23,267,231 shares of common stock to the shareholders of Cannavoices, representing approximately 97.7% of the Company’s outstanding shares of common stock, following the closing of the Merger Agreement, in exchange for the cancellation of all of the issued and outstanding shares of common stock of Cannavoices. The sole officer, one of the directors and, prior to closing of the Merger Agreement, the largest stockholder of Cannavoices was Kevin Gillespie, who is also the Chief Executive Officer, President, director and largest stockholder of the Company. Cannavoices was incorporated on June 5, 2015 as a Florida corporation. Effective on the Closing Date, pursuant to the Merger Agreement, Cannavoices became a wholly-owned subsidiary of the Company. The acquisition of Cannavoices is treated as a reverse acquisition, and the business of Cannavoices became the business of the Company. Cannavoices was deemed the accounting acquirer, while the Company was deemed the legal acquirer. At the time of the reverse recapitalization, the Company was not engaged in any active business. The consolidated financial statements of the Company are those of Arias Intel Corp. and of the consolidated subsidiaries from the Closing Date and subsequent periods. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of December 31, 2017 and for the three and nine months ended December 31, 2017 and 2016, respectively. The results of operations for the three and nine months ended December 31, 2017 are not necessarily indicative of the operating results for the full year ending March 31, 2018, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the financial statements and related disclosures of the Company as of March 31, 2017 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on June 30, 2017.

Going Concern and Management's

Going Concern and Management's Plan	9 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern and Management's Plan	2. GOING CONCERN AND MANAGEMENT’S PLAN These financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated revenue during the three and nine months ended December 31, 2017, and incurred a net loss of $2,731,841 and $9,494,826 for the three and nine months ended December 31, 2017, respectively. The Company has an accumulated deficit of $16,557,211 as of December 31, 2017. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise money from either equity or debt financing, and the attainment of profitable operations from the Company’s future business. Additionally, the Company is actively seeking strategic alliances in order to accelerate its growth in the industry. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year from the date these financial statements are issued. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its subsidiaries, including Cannavoices, Inc. and FH Acquisition Corp. (“FHA”). All significant intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to amounts in prior periods to conform to the current period presentation. All reclassifications have been applied consistently to the periods presented. The reclassifications had no impact on net loss or total assets and liabilities. Consolidated Variable Interest Entity (“VIE”) On September 1, 2016, Cannavoices entered into a share exchange agreement with FHA, whereby all the issued and outstanding capital stock of FHA was exchanged for an aggregate of 1,334,262 shares of the Cannavoices’ common stock. FHA shares were exchanged on a one-for-one basis with the shares of the Cannavoices’ common stock. Effective on the date of the share exchange agreement, FHA became a wholly-owned subsidiary of the Company. The Company previously determined FHA was a VIE and Cannavoices was the primary beneficiary. This was concluded as FHA collected capital raised from investors and funded invoices of Cannavoices as directed by the Cannavoices’ Board of Directors. The Company has presented the financial statements on a consolidated basis since FHA’s inception (November 23, 2015). Accordingly, intercompany activity between the Company and FHA are eliminated in consolidation. Use of Estimates The financial statements and accompanying notes are prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates and assumptions include the fair value of the Company’s stock and the valuation allowance relating to the Company’s deferred tax assets. Revenue Recognition In accordance with the Securities and Exchange Commission’s (“SEC”) Staff Accounting Bulletin (“SAB”) Topic 13, Revenue Recognition Stock-Based Compensation The Company accounts for stock-based compensation in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718 “Compensation – Stock Compensation” using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. The Company accounts for stock-based compensation to consultants and other third parties in accordance with ASC 505-50 “Equity-Based Payments to Non-Employees.” Compensation expense is determined at the “measurement date.” Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date. Dividends The Company has not adopted any policy regarding payment of dividends. No dividends have been paid during any of the periods shown. Advertising Costs The Company’s policy regarding advertising is to expense advertising when incurred. The Company did not incur any advertising expense for the three and nine months ended December 31, 2017 and December 31, 2016, respectively. Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three months or less when purchased to be cash equivalents, to the extent the funds are not being held for investment purposes. As at December 31, 2017 and March 31, 2017, the Company had no cash equivalents. Fair Value of Financial Instruments The carrying amounts (if any) of cash, accounts payable, and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company measures the fair value of financial assets and liabilities based on the guidance of the FASB ASC in accordance with U.S. GAAP, ASC 820 “Fair Value Measurements and Disclosures”, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions) Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable ASC 480-10. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company’s own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company’s free-standing derivatives consisted of warrants to purchase common stock that were issued in connection with the issuance of debt and of embedded conversion options with convertible debentures. The Company evaluated these derivatives to assess their proper classification in the balance sheet as of December 31, 2017 using the applicable classification criteria enumerated under ASC 815-Derivatives and Hedging. The Company determined that certain embedded conversion and/or exercise features do not contain fixed settlement provisions. The convertible debentures contain a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the derivatives which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period. Net Loss per Common Share Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Although there were common stock equivalents as of December 31, 2017, they were anti-dilutive. For the Three Months Ended For the Three Months Ended Net Loss $ (2,731,841 ) $ (475,793 ) Weighted Average Shares 30,326,520 23,223,187 Net Loss Per share $ (0.09 ) $ (0.02 ) For the Nine Months Ended For the Nine Months Ended Net Loss $ (9,494,826 ) $ (3,376,593 ) Weighted Average Shares 28,406,108 22,036,635 Net Loss Per share $ (0.33 ) $ (0.15 ) The following financial instruments were not included in the diluted loss per share calculation as of December 31, 2017 and 2016 because their effect was anti-dilutive: As of December 31 2017 2016 Warrants to purchase Common Stock $ 578,668 $ - Convertible notes 1,743,924 514,368 Total $ 2,322,592 $ 514,368 Income Taxes The Company provides for income taxes under ASC 740 “Accounting for Income Taxes”. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. The Company classifies interest expense and any related penalties related to income tax uncertainties as a component of income tax expense. No interest or penalties have been recognized as of and for the quarters ended December 31, 2017 and 2016. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Impairment of Long-Lived Assets The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. Recent Accounting Pronouncements In August 2017, the FASB issued Accounting Standards Update (“ASU”) No. 2017-12, Derivatives and Hedging, Targeted Improvements to Accounting for Hedging Activities. The amendments in ASU 2017-12 provided guidance to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results in the financial statements. The amendments expand and refine hedge accounting for both nonfinancial and financial risk components and align the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. For public business entities, the amendments in ASU 2017-12 are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. While the Company does not expect the adoption of ASU 2017-12 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2017-12 may have on its financial position, results of operations or cash flows. In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (“EPS”) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. While the Company does not expect the adoption of ASU 2017-11 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2017-11 may have on its financial position, results of operations or cash flows. In May 2017, FASB issued ASU 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting, which amends the scope of modification accounting surrounding share-based payment arrangements as issued in ASU 2016-09 by providing guidance on the various types of changes which would trigger modification accounting for share-based payment awards. ASU 2017-09 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods, which would be the Company’s fiscal year ending March 31, 2019. Early adoption is permitted, including adoption in any interim period, for public business entities for reporting periods for which financial statements have not yet been issued. While the Company does not expect the adoption of ASU 2017-09 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2017-09 may have on its financial position, results of operations or cash flows. In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, to improve and simplify the accounting for the income tax consequences of intra-entity transfers of assets other than inventory, requiring companies to recognize income tax consequences upon the transfer of the asset to a third party. ASU 2016-16 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods, which would be the Company’s fiscal year ending March 31, 2019. While the Company does not expect the adoption of ASU 2016-16 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2016-16 may have on its financial position, results of operations or cash flows. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, which will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The Company does not expect the adoption of ASU 2016-15 to have a material effect on its business, its financial position, results of operations or cash flows. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation – Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 simplifies the accounting for several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods, which would be the Company’s fiscal year ending March 31, 2018. The Company does not expect the adoption of ASU 2016-09 to have a material effect on its business, its financial position, results of operations or cash flows. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters into a lease, with some specified scope exemptions. The guidance in this update supersedes Topic 840, Leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For public companies, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, which would be the Company’s fiscal year ending March 31, 2020. The Company does not expect the adoption of ASU 2016-09 to have a material effect on its business, its financial position, results of operations or cash flows. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments and requires entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, and the separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (i.e., securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements. The guidance is effective for annual and interim reporting periods beginning after December 15, 2017. The Company expects that this guidance will not have a material effect on its financial statements. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,”, which requires entities to present deferred tax assets and deferred tax liabilities as noncurrent in a classified balance sheet. The ASU simplifies the current guidance in ASC 740, which requires entities to separately present deferred tax assets and liabilities as current and noncurrent in a classified balance sheet. ASU 2015-17 is effective for fiscal years beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for all entities as of the beginning of an interim or annual reporting period. The Company expects that this guidance will not have a material effect on its financial statements. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements—Going Concern,” which impacts the accounting guidance related to the evaluation of an entity’s ability to continue as a going concern. The amendment establishes management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern in connection with preparing financial statements for each annual and interim reporting period. The amendment also gives guidance to determine whether to disclose information about relevant conditions and events when there is substantial doubt about an entity’s ability to continue as a going concern. The amended guidance is effective prospectively for fiscal years beginning after December 15, 2016. The Company has adopted this new guidance effective as of the inception date. The adoption of this ASU did not have a material impact on the Company’s financial position, results of operations or cash flows. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) which amended the existing accounting standards for revenue recognition. ASU 2014-09 establishes principles for recognizing revenue upon the transfer of promised goods or services to customers, in an amount that reflects the expected consideration received in exchange for those goods or services. In July 2015, the FASB deferred the effective date for annual reporting periods beginning after December 15, 2017 (including interim reporting periods within those periods). Early adoption is permitted to the original effective date for annual reporting periods beginning after December 15, 2016 (including interim reporting periods within those periods). The amendments may be applied retrospectively to each prior period (full retrospective) or retrospectively with the cumulative effect recognized as of the date of initial application (modified retrospective). The Company will adopt ASU 2014-09 beginning April 1, 2018 and apply the full retrospective approach. Until such time as the Company makes an acquisition or commences monetizing its assets, the Company does not know what the impact of this new standard will be or if it will impact the Company’s disclosure.

Convertible Promissory Note Rec

Convertible Promissory Note Receivable	9 Months Ended
	Dec. 31, 2017
Receivables [Abstract]
Convertible Promissory Note Receivable	4. CONVERTIBLE PROMISSORY NOTE RECEIVABLE On March 31, 2016, the Company purchased a convertible promissory note from a related party (the “Assignor”) in the principal amount of $100,000. The convertible promissory note was assigned to the Company for $100,000 in cash consideration and the Assignor of the convertible promissory note relinquished any further participating interest. The convertible promissory note accrues interest at 6% compounded annually and matured on November 30, 2017. On October 20, 2017, the maturity date of this note was amended to October 31, 2019. The convertible promissory note is convertible into equity of the issuer of the note, a social media company, upon events not certain to occur as of December 31, 2017. The balance of the convertible promissory note receivable, including accrued interest at December 31, 2017 and March 31, 2017 was $110,500 and $106,000, respectively. For the three and nine months ended December 31, 2017 and 2016, the Company recognized $1,500 and $4,500 in interest income, respectively.

Asset Purchase Agreement - Inte

Asset Purchase Agreement - Intellectual Property	9 Months Ended
	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Asset Purchase Agreement - Intellectual Property	5. ASSET PURCHASE AGREEMENT – INTELLECTUAL PROPERTY On July 17, 2017, the Company entered into an asset purchase agreement (the “Agreement”) with Interactive Systems Worldwide, Inc. (“ISWI”). Pursuant to the Agreement, the Company purchased the proprietary intellectual property assets ® SportXction ® As consideration for the IP Assets, the Company issued ISWI an aggregate of 2,000,000 shares of Company’s restricted common stock. The Company determined the valuation of the 2,000,000 shares should be at the most recent arms-length transaction price of $1.00 per share or $2,000,000 to reflect the fair value of the consideration purchased based on future earnings assumptions utilizing the IP Assets. The Company considers stock sales to independent investors to be a better indicator of the true fair value of the Company’s restricted common stock based on its limited trading market and lack of liquidity. The asset purchase was an arms-length transaction from an independent third party. The Company recorded the intangible IP Assets at the fair value of the consideration transferred of $2,000,000. The Company has determined to amortize the IP Assets over three years on a straight-line basis. For the nine months ended December 31, 2017, the Company incurred $305,023 in amortization expense.

Note Payable

Note Payable	9 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Note Payable	6. NOTE PAYABLE On April 27, 2016, the Company issued a promissory note in the principle amount of $600,000, net of associated discount of $20,000. The note bears interest at a rate of 15% per annum and interest payments were to be paid monthly beginning June 1, 2016. The Company has the right to prepay the note at any time without penalty. The promissory note is secured by a security interest in all of the assets of the Company. The principal and accrued interest of the note became due and payable by the Company on the one-year anniversary date of the note, or April 27, 2017. Although the Company reached an agreement with the holder of the promissory note to extend the maturity date until July 1, 2017, the promissory note is currently in default and a lawsuit has been commenced against the Company by the holder thereof. See Note 13. – Commitments and Contingencies. The outstanding principal of the promissory note at December 31, 2017 and March 31, 2017 was $600,000 and $598,333, respectively. For the three months ended December 31, 2017 and 2016, the Company recognized $22,500 and $62,500 in interest expense and amortization of debt discount of $0 and $1,667, respectively, included in interest expense in the accompanying statement of operations. For the nine months ended December 31, 2017 and 2016, the Company recognized $62,500 and $52,500 in interest expense and amortization of debt discount of $1,667 and $13,336, respectively, included in interest expense in the accompanying statement of operations. As of December 31, 2017 and December 31, 2016, the Company recorded $60,000 and $0 in accrued interest expense, respectively.

Convertible Promissory Notes Pa

Convertible Promissory Notes Payable	9 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Convertible Promissory Notes Payable	7. CONVERTIBLE PROMISSORY NOTES PAYABLE On November 10, 2016, the Company entered into a convertible short-term promissory note (the “November Short-Term Note”) with a lender that has an outstanding principal balance of $6,250 plus accrued interest of $2,646 at September 30, 2017. The Company reached a verbal agreement with the holder of the November Short-Term Note to extend the maturity date of such note until October 5, 2017 and the note continues to accrue interest at a rate of 10% per annum. On October 5, 2017, the Company repaid the holder of the November Short-Term Note the principal balance of $6,250 plus accrued interest of $2,646. The principal balance outstanding as of December 31, 2017 is $0. On July 18, 2017, the Company entered into a series of convertible short-term promissory notes (the “July Short-Term Notes”) with lenders pursuant to which the lenders advanced the Company an aggregate of $50,000. Interest on such notes accrues at a rate of 10% per annum and is due at maturity. The principal and accrued interest on the July Short-Term Notes became due and payable by the Company on the ninety-day anniversary date of the July Short-Term Notes, or October 16, 2017. On October 18, 2017, the July Short-Term Notes and the related accrued interest of $1,260 were converted into an aggregate of 51,260 shares of the Company’s common stock. On August 3, 2017, the Company entered a convertible short-term promissory note (the “August 3 rd rd rd rd On August 14, 2017, the Company entered into a series of convertible short-term promissory notes (the “August 14 th th th th th On August 17, 2017, the Company entered into a convertible short-term promissory note (the “August 17 th th th th On September 5, 2017, the Company entered a convertible short-term promissory note (the “September 5 th th th th On September 29, 2017, the Company entered a convertible short-term promissory note (the “September 29 th th th th On October 11, 2017, the Company entered into a series of convertible short-term promissory notes (the “October 11 th th th th On October 11, 2017, the Company entered into a convertible short-term promissory note (the “October 11 th th th th th On November 9, 2017, the Company entered into a convertible short-term promissory note (the “November 9 th th th th On December 13, 2017, the Company entered into a series of convertible short-term promissory notes (the “December 13 th th th th Due to the nature of the issued convertible notes payable notes described below, the Company determined that the conversion feature requires classification as an embedded derivative. The accounting treatment requires that the Company record at fair value at inception as a liability and to fair value as of each subsequent reporting date which at December 31, 2017 was $1,672,175. The fair value of the embedded derivatives at issuance of the convertible notes payable were determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 228.13% to 260.33%, (3) weighted average risk-free interest rate of 0.44% to 1.35%, (4) expected lives of 0.25 to 0.49 years, and (5) estimated fair value of the Company’s common stock from $1.00 to $1.50 per share.

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Convertible Notes Payable	8. CONVERTIBLE NOTES PAYABLE Convertible notes payable were comprised of the following as of December 31, 2017 and March 31, 2017: December 31, 2017 March 31, 2017 Auctus Fund LLC notes payable $ 259,500 $ - EMA Financial LLC 259,500 - Total notes payable 519,000 - Less unamortized debt discount (156,959 ) - Total notes payable net of unamortized debt discount 362,041 - Less current portion (362,041 ) - Long term portion $ - $ - Auctus Fund LLC During the nine months ended September 30, 2017, the Company entered into Securities Purchase Agreements with Auctus Fund LLC (“Auctus”) for the sale of 12% convertible promissory notes in aggregate principal amount of $259,500. On April 7, 2017, the Company issued Auctus a convertible promissory note in the principal amount of $175,000 (the “Auctus April Note”) and on May 15, 2017, the Company issued Auctus a convertible promissory note in the principal amount of $84,500 (the “Auctus May Note” and together with the Auctus April Note, the “Auctus Notes”). In connection with the issuance of the Auctus Notes, the Company issued five-year warrants (the “Auctus Warrants”) to purchase up to 125,000 shares of the Company’s common stock at an exercise price of $2.00 per share, subject to adjustment. The Auctus Notes bear interest at the rate of 12% per annum. Any amount of principal or interest on the Auctus Notes which is not paid when due shall bear interest at the rate of 24% per annum from the due date thereof until the same is paid (the “Auctus Default Interest”). All interest and principal must be repaid one year from the issuance date. The Auctus May Note is due on May 15, 2018 and the Auctus April Note is due on April 7, 2018. The Company has identified the embedded derivatives related to the Auctus Notes and Auctus Warrants. These embedded derivatives included certain conversion features and reset provisions. The Auctus May Note is convertible into shares of the Company’s common stock at any time at a conversion price equal to the lesser of (i) a 50% discount to the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading days prior to May 15, 2017 and (ii) 50% of the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading day period prior to conversion. The Auctus April Note is convertible into shares of the Company’s common stock at any time at a conversion price equal to the lesser of (i) a 60% discount to the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading days prior to April 7, 2017 and (ii) 60% of the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading day period prior to conversion. If, at any time while the Auctus Notes are issued and outstanding, the Company issues or sells, or is deemed to have issued or sold shares of common stock, except for shares of common stock issued directly to vendors or suppliers of the Company in satisfaction of amounts owed to such vendors or suppliers (provided, however, that such vendors or suppliers shall not have an arrangement to transfer, sell or assign such shares of common stock prior to the issuance of such shares), for no consideration or for a consideration per share (before deduction of reasonable expenses or commissions or underwriting discounts or allowances in connection therewith) less than the conversion price of the Auctus Notes that is then in effect on the date of such issuance of such shares of common stock (a “Auctus Dilutive Issuance”), then immediately upon the Auctus Dilutive Issuance, the conversion price of the Auctus Notes will be reduced to the amount of the consideration per share received by the Company in such Auctus Dilutive Issuance. Auctus does not have the right to convert the Auctus Notes into shares of the Company’s common stock if such conversion would result in Auctus’ beneficial ownership exceeding 4.99% of our outstanding common stock at such time. All amounts due under the Auctus Note become immediately due and payable by us upon the occurrence of an event of default, including but not limited to, (i) our sale of all or substantially all of our assets, (ii) our failure to pay the amounts due at maturity, (iii) our failure to issue shares of common stock upon any conversion of the Auctus Notes, (iv) our breach of the covenants, representations or warranties pursuant to the Auctus Notes, (v) our appointment of a trustee, (vi) a judgment against us in excess of $100,000 (subject to a 20 day cure period), (vii) our liquidation, (viii) the filing of a bankruptcy petition by us or against us, (ix) our failure to comply with the reporting requirements of the Securities Exchange Act of 1934, (x) the delisting of our common stock from the OTC Pink or equivalent exchange, (xi) a restatement of our financial statements for any period from two years prior to the issuance date of the Auctus Notes until such notes have been paid in full, or (xi) our effectuation of a reverse stock split without 20 days prior written notice to Auctus. We are required to pay an amount equal to 150% times the sum of the then outstanding principal amount of the Auctus Notes together with accrued interest thereon with Auctus Default Interest (collectively, the “Default Sum”) for failure to pay the principal amount of the Auctus Notes together with interest accrued thereon when due at the maturity date. In addition, we shall be required to pay Auctus $2,000 per day, for each day beyond the date that we are required to deliver shares of common stock to Auctus upon conversion of the Auctus notes. Pursuant to the Auctus May Note, at any time the Company consummates a financing transaction, the Company is required to apply at least 60% of the proceeds from such sales towards the payment of the Auctus May Note. In addition, the Auctus May Note contains a prohibition with respect to the consummation of a transaction involving capital raising or financing from any party through the sale of debt and/or equity securities for a period of at least 90 days after the issuance date of the Auctus May Note, or until August 13, 2017, without the consent of Auctus. Finally, the Auctus Notes have a cross-default provision whereby a default of the Auctus May Note constitutes a default of the Auctus April Note. See Note 14. – Commitments and Contingencies. The Company agreed to reserve an aggregate of 2,445,000 shares of common stock for conversions of the Auctus Notes (the “Auctus Reserve”), and also agreed to adjust the Auctus Reserve to ensure that such reserve always equals at least ten times the total number of shares of common stock that is issuable upon conversion of the Auctus Notes. The Auctus Warrants are immediately exercisable and may be exercised on a cashless basis in the event that the shares of common stock underlying the Auctus Warrants are not registered for resale with the SEC on an effective registration statement. The exercise price of the Auctus Warrants is subject to adjustment for stock dividends and splits, and also subject to dilution protection in the event that the Company issues shares of common stock or securities convertible into common stock at an effective price per share that is less than the original exercise price of the Auctus Warrants. On November 9, 2017, the Company received a notice of default from Auctus with respect to the Auctus Notes, and Auctus commenced a lawsuit against the Company on November 27, 2017. Auctus alleged the Company failed to apply at least 60% of the proceeds from financing transactions consummated during its second quarter ended September 30, 2017 towards the repayment of the Auctus May Note and the Company also failed to adhere to the prohibition of the Auctus May Note, which prohibited financing transactions by the Company for at least 90 days following the issuance of such note, without prior written consent of Auctus, giving rise to an event of default. In addition, Auctus alleged a breach of the Auctus May Note resulted in a breach of the Auctus April Note by virtue of the cross-default provision contained in the Auctus April Note. At December 31, 2017, the Auctus Notes were disputed, contingent and unliquidated, and the Company intended to litigate such allegations if a resolution could not be agreed upon by all of the parties involved. At that time, it could not be determined whether the court would find the Auctus Notes in default as alleged in the Auctus compliant. In addition, the amount of any prejudgment cost, fees or penalties were not determinable and were not accrued for by the Company as of December 31, 2017. The Company has recorded the Auctus Notes as a liability at its principal balance and continued to accrue interest as of December 31, 2017. The parties entered into a settlement agreement on January 24, 2018. See Note 14. – Subsequent Events. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of Auctus Notes and to fair value as of each subsequent reporting date which at December 31, 2017 was $502,590 and $1,241,360 for the debt derivative and warrant liability, respectively. At the inception of the Auctus Notes, the Company determined the aggregate fair value of $811,555 and $423,011 of the embedded debt derivatives and warrant liability, respectively. EMA Financial LLC During the nine months ended September 30, 2017, the Company entered into Securities Purchase Agreements with EMA Financial LLC (“EMA”) for the sale of 12% convertible promissory notes in aggregate principal amount of $259,500. On April 10, 2017, the Company issued EMA a convertible promissory note in the principal amount of $175,000 (the “EMA April Note”) and on May 15, 2017, the Company issued EMA a convertible promissory note in the principal amount of $84,500 (the “EMA May Note” and together with the EMA April Note, the “EMA Notes”). In connection with the issuance of the EMA Notes, the Company issued five-year warrants (the “EMA Warrants”) to purchase up to 125,000 shares of the Company’s common stock at an exercise price of $2.00 per share, subject to adjustment. The EMA Notes bear interest at the rate of 12% per annum. Any amount of principal or interest on the EMA Notes which is not paid when due shall bear interest at the rate of 24% per annum from the due date thereof until the same is paid (the “EMA Default Interest”). All interest and principal must be repaid one year from the issuance date. The EMA May Note is due on May 15, 2018 and the EMA April Note is due on April 7, 2018. The Company has identified the embedded derivatives related to the EMA Notes and EMA Warrants. These embedded derivatives included certain conversion features and reset provisions. The EMA May Note is convertible into shares of the Company’s common stock at any time on or after 180 days following May 15, 2017 at the lower of (i) the closing sale price of the common stock on the principal market on the trading day immediately preceding the closing date and (ii) 50% of the lowest sale price for the common stock on the principal market during the 25 consecutive trading days immediately preceding the date of conversion. If the Company fails to register the shares of common stock underlying the EMA May Note within 180 days of the closing date, the conversion price will be permanently reduced to: (i) the closing sale price of the common stock on the principal market on the trading day immediately preceding the closing date and (ii) 50% of the lowest sale price for the common stock on the principal market during the 25 consecutive trading days immediately preceding the conversion date. As of December 31, 2017, the Company has not registered the shares of common stock underlying the EMA May Note. The EMA April Note is convertible into shares of the Company’s common stock at any time on or after 180 days following April 10, 2017 at the lower of (i) the closing sale price of the common stock on the principal market on the trading day immediately preceding the closing date and (ii) 60% of the lowest sale price for the common stock on the principal market during the 25 consecutive trading days immediately preceding the date of conversion. If the Company fails to register the shares of common stock underlying the EMA May Note within 180 days of the issue date, the conversion price will be permanently reduced to: (i) the closing sale price of the common stock on the principal market on the trading day immediately preceding the closing date and (ii) 40% of the lowest sale price for the common stock on the principal market during the 25 consecutive trading days immediately preceding the conversion date. As of December 31, 2017, the Company has not registered the shares of common stock underlying the EMA April Note. EMA does not have the right to convert the EMA Notes into shares of the Company’s common stock if such conversion would result in EMA’s beneficial ownership exceeding 4.99% of our outstanding common stock at such time. All amounts due under the EMA Notes become immediately due and payable by us upon the occurrence of an event of default, including but not limited to, (i) our sale of all or substantially all of our assets, (ii) our failure to pay the amounts due at maturity, (iii) our failure to issue shares of common stock upon any conversion of the EMA Notes, (iv) our breach of the covenants, representations or warranties pursuant to the EMA Notes, (v) our appointment of a trustee, (vi) a judgment against us in excess of $50,000 (subject to a 20 day cure period), (vii) our liquidation, (viii) the filing of a bankruptcy petition by us or against us, (ix) our failure to comply with the reporting requirements of the Securities Exchange Act of 1934, (x) the delisting of our Common Stock from the OTC Pink or equivalent exchange, (xi) a restatement of our financial statements for any period from two years prior to the issuance date of the EMA Notes until the EMA Notes have been paid in full, or (xi) our effectuation of a reverse stock split without 10 days prior written notice to EMA. We are required to pay an amount equal to 150% times the sum of the then outstanding principal amount of the EMA Notes together with accrued interest thereon with EMA Default Interest (collectively, the “EMA Default Sum”) for failure to pay the principal amount of the EMA Notes together with interest accrued thereon when due at the maturity date. In addition, we shall be required to pay EMA $1,000 per day, for each day beyond the date that we are required to deliver shares of common stock to EMA upon conversion of the EMA notes. If at any time the Company enters into any capital raising transaction, including without limitation an equity line transaction, a loan transaction or the sale of shares of common stock or securities convertible into or exercisable or exchangeable for common stock, then five trading days following the closing of such subsequent financing, at least 60% of the gross proceeds therefrom shall be paid to EMA to redeem a portion of the EMA Notes pursuant to the terms thereof. The Company agreed to reserve an aggregate of 2,445,000 shares of common stock for conversions of the EMA Notes (the “EMA Reserve”), and also agreed to adjust the EMA Reserve to ensure that such reserve always equals at least ten times the total number of common stock that is issuable upon conversion of the EMA Notes. The EMA Warrants are immediately exercisable and may be exercised on a cashless basis in the event that the shares of common stock underlying the EMA Warrants are not registered for resale with the SEC on an effective registration statement. The exercise price of the EMA Warrants is subject to adjustment for stock dividends and splits, and also subject to dilution protection in the event that the Company issues shares of common stock or securities convertible into common stock at an effective price per share that is less than the original exercise price of the EMA Warrants. Pursuant to the EMA Securities Purchase Agreements, in the event that at any time on or prior to the date which is six months following the issuance date, the Company desires to borrow funds, raise additional capital and/or issue additional promissory notes, whether convertible into shares of securities of the Company or otherwise (a “Prospective Financing”), EMA shall have the right of first refusal to participate in the Prospective Financing, and the Company shall provide written notice containing the terms of such Prospective Financing to EMA prior to effectuating any such transaction, provided that this right shall not apply to (a) any transaction in which the Company receives more than $250,000 of net proceeds in a single transaction or (b) any transaction that does not involve the issuance of any securities which are directly or indirectly convertible, exercisable or exchangeable into or for capital stock of the Company. On September 1, 2017, the Company received a notice of default from EMA with respect to the EMA Notes, and EMA commenced a lawsuit against the Company on October 19, 2017. EMA alleges that the Company failed to file a registration statement covering the resale of the shares of common stock underlying the EMA Notes thus giving rise to an event of default. The EMA Notes are disputed, contingent and unliquidated, and the Company intends to litigate such allegations if a resolution cannot be agreed upon by all of the parties involved. It cannot be determined at this time whether the court will find the EMA Notes in default as alleged in the EMA compliant. In addition, the amount of any prejudgment cost, fees or penalties are not determinable at this time and have not been accrued for by the Company as of December 31, 2017. The Company has recorded the EMA Notes as a liability at its principal balance and continues to accrue interest at the stated rate of 12% per annum. The Company filed a Motion to Dismiss the Complaint based on the criminal usury defense under New York law on January 18, 2018. EMA filed a Motion for Summary Judgment on the Complaint on February 2, 2018. The Company cannot determine at this time whether the court will agree with the Company’s position; however, the Company intends to litigate such allegations if a resolution cannot be agreed upon by the Company and EMA. The actions are still pending. See Note 14. – Commitments and Contingencies. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of EMA Notes and to fair value as of each subsequent reporting date which at December 31, 2017 was $584,914 and $1,241,360 for the debt derivative and warrant liability, respectively. At the inception of the EMA Notes, the Company determined the aggregate fair value of $979,651 and $419,280 of the embedded debt derivatives and warrant liability, respectively. Summary: The Company has identified the embedded derivatives and warrant liability related to the Auctus and EMA promissory notes and related issued warrants. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of these notes and to fair value as of each subsequent reporting date which at December 31, 2017 was $1,087,504 and $2,482.719 for the debt derivative and warrant liability, respectively. The fair value of the embedded derivatives and warrant liability at issuance of the Auctus and EMA promissory notes, were determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 234.00% to 245.43%, (3) weighted average risk-free interest rate of 1.07% to 1.92%, (4) expected lives of 1.00 to 5.00 years, and (5) estimated fair value of the Company’s common stock from $1.50 to $3.74 per share. The initial fair value of the embedded debt derivative and warrant liability in aggregate of $2,633,498 was allocated as a debt discount up to the proceeds of the notes ($470,500) with the remainder ($2,162,998) charged to current period operations as interest expense. For the three and nine months ended December 31, 2017, the Company amortized an aggregate of $130,816 and $362,041 of debt discounts to current period operations as interest expense, respectively.

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	9. DERIVATIVE LIABILITIES Warrant liability In fiscal 2017, in connection with the issuance of convertible promissory notes, as discussed in Note 8, the Company issued five-year warrants to purchase an aggregate of 250,000 shares of the Company’s common stock at an exercise price of $2.00 per share with anti-dilutive (reset) provisions. The Company has identified embedded derivatives related to the issued warrants. These embedded derivatives included certain anti-dilutive (reset) provisions. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date and to fair value as of each subsequent reporting date. At December 31, 2017, the fair value of the reset provision related to the embedded warrant liability of $2,482,719 was determined using the Binomial Option Pricing model with the following assumptions: dividend yield: 0%; volatility: 235.92%; risk free rate: 1.92%; and expected life: 4.52 to 4.62 years. The Company recorded a loss on change in warrant liabilities of $1,640,428 during the nine months ended December 31, 2017. Convertible notes In fiscal 2017, the Company issued convertible promissory notes. These promissory notes are convertible into common stock, at the holders’ option, at a discount to the market price of the Company’s common stock. The Company has identified the embedded derivatives related to these promissory notes relating to certain anti-dilutive (reset) provisions. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of these notes and to fair value as of each subsequent reporting date. The fair value of the embedded derivatives at September 30, 2017, in the amount of $2,720,852, was determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 229.88%, (3) weighted average risk-free interest rate of 1.39% to 1.53%, (4) expected lives of 0.08 to 0.62 years, and (5) estimated fair value of the Company’s common stock of $2.00 per share. The Company recorded a loss on change in derivative liabilities of $84,135 during the nine months ended December 31, 2017. Based upon ASC 840-15-25 (Emerging Issues Task Force, or EITF, Issue 00-19, paragraph 11) the Company has adopted a sequencing approach regarding the application of ASC 815-40 to its outstanding convertible promissory notes. Pursuant to the sequencing approach, the Company evaluates its contracts based upon earliest issuance date.

Fair Value Measurement

Fair Value Measurement	9 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurement	10. FAIR VALUE MEASUREMENT The Company adopted the provisions of ASC subtopic 825-10, Financial Instruments. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. All items required to be recorded or measured on a recurring basis are based upon level 3 inputs. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. Upon adoption of ASC 825-10, there was no cumulative effect adjustment to beginning retained earnings and no impact on the financial statements. The carrying value of the Company’s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. As of December 31, 2017 and March 31, 2017, the Company did not have any items that would be classified as level 1 or 2 disclosures. The Company recognizes its derivative liabilities as level 3 and values its derivatives using the methods discussed in Notes 8 and 9. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed in Notes 8 and 9 are that of volatility and market price of the underlying common stock of the Company. As of December 31, 2017 and March 31, 2017, the Company did not have any derivative instruments that were designated as hedges. The derivative and warranty liabilities as of December 31, 2017, in the amount of $5,203,571 have a level 3 classification. The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of December 31, 2017: Warrant Liability Debt Derivative Balance, March 31, 2017 $ - $ - Total (gains) losses Initial fair value of debt derivative at note or warrant issuance 842,291 2,494,699 Mark-to-market at December 31, 2017: 1,640,428 (84,135 ) Balance, December 31, 2017 2,482,719 2,410,564 Net gain (loss) for the period included in earnings relating to the liabilities held at December 31, 2017 $ (1,640,428 ) $ (84,135 ) Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. The Company’s stock price decreased approximately 100% from April 7, 2017 to September 30, 2017. As the stock price decreases for each of the related derivative instruments, the value to the holder of the instrument generally decreases. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The estimated fair value of these liabilities is sensitive to changes in the Company’s expected volatility. Increases in expected volatility would generally result in a higher fair value measurement.

Stockholders' Equity and Contri

Stockholders' Equity and Contributed Capital	9 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Stockholders' Equity and Contributed Capital	11. STOCKHOLDERS’ EQUITY AND CONTRIBUTED CAPITAL Recent Sale of Securities The Company is authorized to issue up to 500,000,000 shares of common stock, $0.001 par value. The Company is authorized to issue up to 10,000,000 of blank check preferred stock, $0.001 par value. As of December 31, 2017, the Company had 30,455,167 shares of common stock and 0 shares of preferred stock issued and outstanding, respectively. In April 2017, the Company issued 67,653 shares of common stock at $0.75 per share, upon the conversion of a convertible note and accrued interest thereon of $50,740. In April 2017, the Company issued an aggregate of 120,957 shares of common stock at $1.00 per share, upon the conversion of convertible notes and accrued interest thereon of $120,957. In April 2017, the Company issued an aggregate of 902,500 shares of common stock to individuals for services valued at $902,500. In May 2017, the Company sold an aggregate of 258,000 shares of common stock at $1.00 per share, for gross proceeds of $258,000. In May 2017, the Company issued an aggregate of 21,559 shares of common stock at $1.00 per share, upon the conversion of convertible notes payable and accrued interest of $21,559. In May 2017, the Company issued an aggregate of 159,883 shares of common stock to individuals for services valued at $159,883. In June 2017, the Company sold an aggregate of 30,000 shares of common stock at $1.00 per share, for gross proceeds of $30,000. In June 2017, the Company issued 30,838 shares of common stock at $1.00 per share, upon the conversion of a convertible note and accrued interest thereon of $30,838. On July 17, 2017, the Company issued 2,000,000 shares of common stock for the IP Assets purchased from ISWI valued at $2,000,000. In July 2017, the Company sold 3,000 shares of common stock at $1.00 per share, for gross proceeds of $3,000. In July 2017, the Company issued 266,667 shares of common stock at $0.75 per share, upon the conversion of a convertible note of $200,000. In July 2017, the Company issued an aggregate of 575,000 shares of common stock to individuals for services valued at $575,000. In August 2017, the Company issued an aggregate of 668,750 shares of common stock to individuals for services valued at $668,750. In September 2017, the Company sold an aggregate of 116,667 shares of common stock at $1.50 per share, for gross proceeds of $175,000. In September 2017, the Company issued an aggregate of 128,084 shares of common stock at $1.00 per share, upon the conversion of convertible notes and accrued interest thereon of $128,084. In September 2017, the Company issued an aggregate of 177,500 shares of common stock to individuals for services valued at $266,250. In October 2017, the Company issued an aggregate of 51,260 shares of common stock at $1.00 per share, upon the conversion of convertible notes and accrued interest thereon of $51,260. In October 2017, the Company sold an aggregate of 20,700 shares of common stock at $1.50 per share, for gross proceeds of $31,050. In October 2017, the Company issued an aggregate of 40,000 shares of common stock to individuals for services valued at $30,000. In November 2017, the Company sold an aggregate of 23,634 shares of common stock at $1.50 per share, for gross proceeds of $33,450. In November 2017, the Company sold 2,000 shares of common stock at $1.00 per share, for gross proceeds of $2,000. In December 2017, the Company sold 3,333 shares of common stock at $1.50 per share, for gross proceeds of approximately $5,000. In December 2017, the Company sold 4,000 shares of common stock at $1.00 per share, for gross proceeds of $4,000. In December 2017, the Company issued an aggregate of 117,000 shares of common stock to individuals for services valued at $117,000. As of December 31, 2017, there were no stock options granted, warrants to purchase up to 250,000 shares of the Company’s common stock outstanding as granted in the convertible notes financing and warrants to purchase up to 328,668 shares of the Company’s common stock outstanding issued together with the 164,334 shares of common stock sold at $1.50 per share during the nine months ended December 31, 2017. For each common stock sold, the investors received one warrant to purchase one share of common stock exercisable at $2.50 per share for one year from the date of sale and one warrant to purchase one share of common stock exercisable at $5.00 per share for three years from the date of sale. In connection with the foregoing, the Company relied upon the exemption from securities registration provided by Section 4(a)(2) under the Securities Act of 1933, as amended (the “Securities Act”) for transactions not involving a public offering.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions	12. RELATED PARTY TRANSACTIONS The Company’s related parties are First Harvest Financial, Inc. (“FHF”) and The Great American Rolling Paper Company (“GARP”), First Harvest Corp. (“FHC”), Lexington Tech Ventures Management, LLC (“Lexington”), Cannavoices, and FHA by common ownership and management. The related parties have provided certain management services and incurred expenses on behalf of the Company for the three and nine months ended December 31, 2017 and 2016, including accounting, administration, management, marketing, IT support, rent, due diligence and evaluation of acquisition candidates. For the three months ended December 31, 2017 and 2016, the related parties have been reimbursed the following for management and subcontractor fees, respectively: (a) FHF - $8,005 and $16,000, and (b) GARP - $0 and contributed to the Company $26,573. For the nine months ended December 31, 2017 and 2016, the related parties have been reimbursed the following for management and subcontractor fees, respectively: (a) FHF - $36,880 and $164,600, (b) GARP - $0 and contributed to the Company an aggregate of $57,515, (c) FHC - $0 and $200, and (d) Lexington - $0 and $3,000. For the three and nine months ended December 31, 2017, the Company incurred rent expense on behalf FHF of $15,000 and $45,000, respectively. For the three and nine months ended December 31, 2016, the Company incurred rent expense to Cannavoices of $0, and $28,953, respectively. The Company has no formal lease with Cannavoices. For the three and nine months ended December 31, 2016, the Company incurred rent expense to FHA of $23,500 and $51,359, respectively. The Company has no formal lease with FHA. The majority shareholder of the related parties described above is the president and largest shareholder of the Company. For three months ended December 31, 2017 and 2016, he was paid $44,842 and $52,066, respectively. For nine months ended December 31, 2017 and 2016, he was paid $244,073 and $94,457, respectively. He currently has no formal compensation agreement. He is currently involved in other business activities and may, in the future, become involved in other business opportunities. If a specific business opportunity becomes available, he may face a conflict in selecting between the Company and his other business interests. The Company has not formulated a policy for the resolution of such conflicts. The Company entered into a game development and licensing agreement with HKA Digital Limited (“HKA”) on October 2, 2015 (the “Development Agreement”). HKA is majority owned by an officer and director of the Company. For the three months ended December 31, 2017 and 2016, the Company paid HKA $0 and $71,400, respectively. For the nine months ended December 31, 2017 and 2016, the Company paid HKA $199,000 and $572,400, respectively. The total value of the Development Agreement is $2,000,000 based on certain development parameters and ongoing scope of work.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	13. COMMITMENTS AND CONTINGENCIES Litigations, Claims and Assessments In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. There were no such matters that were deemed material to the financial statements as of December 31, 2017, except the following: On August 21, 2017, Hit Sum to Me, LLC (“HSTM”) filed a complaint with the Circuit Court of the First Judicial Circuit in and for Okaloosa County, Florida (Filing #61355697) against Cannavoices and Kevin Gillespie. In the complaint HSTM indicates that on or about April 27, 2016, Cannavoices entered into a Loan Agreement with HSTM and Cannavoices issued a promissory note (the “HSTM Note”) in the principal amount of $600,000, which note is guaranteed by Kevin Gillespie and secured by the Security Agreement for Tangible Personal Property whereby Cannavoices and Kevin Gillespie granted HSTM a first priority security interest in all of the shares of common stock of Cannavoices (the “Cannavoices Stock”). The complaint alleges that Cannavoices breached the terms of the HSTM Note by failing to repay the principal balance of such note by July 1, 2017 and that as of July 1, 2017, Cannavoices is indebted to HSTM in the amount of $600,000 plus accrued and accruing interest, late changes and costs of collection, including attorney’s fees. Pursuant to the complaint, HSTM requests (i) that a judgment be entered against Cannavoices for all amounts owed under the HSTM Note, including damages for principal and interest due under the HSTM Note, late fees and advances, (ii) that a judgment be entered against Kevin Gillespie for all amounts owed under the HSTM Note, including damages for principal and interest due under the HSTM Note, late fees and advances, (iii) that a judgment be entered against Kevin Gillespie for possession of the Cannavoices Stock and (iv) for reasonable attorneys’ fees. The Company filed an answer to the complaint on September 6, 2017. The Company cannot determine at this time whether the court will agree with the Company’s position, but the Company intends to litigate such allegations if a resolution cannot be agreed upon by the Company and HSTM. The action is still pending. See Note 6. – Note Payable. On October 19, 2017, EMA filed a complaint with the United States District Court, Southern District of New York (Case No.: 1:17-cv-08072) against the Company, Cannavoices and FHA. In the complaint, EMA indicated that (i) on April 10, 2017, the Company and EMA entered into a Securities Purchase Agreement (the “EMA April 2017 SPA”) and the Company issued EMA the “EMA April Note” and (ii) on May 15, 2017, the Company and EMA entered into an additional Securities Purchase Agreement (the “EMA May 2017 SPA” and together with the EMA April 2017 SPA, the “SPAs”) and the Company issued EMA the “EMA May Note”. In the complaint EMA alleges that pursuant to the EMA May 2017 SPA and a Registration Rights Agreement dated May 15, 2017, the Company was required to file and have declared effective a registration statement with the SEC for the registration of shares of the Company’s common stock issuable upon the conversion of the EMA Notes. EMA alleges that the Company failed to file a registration statement thus giving rise to an event of default pursuant to the SPAs. Pursuant to the complaint, EMA requests (i) that the Company immediately file a registration statement with the SEC with respect to the shares of the Company’s common stock issuable upon the conversion of the EMA Notes, (ii) that the Company and Cannavoices and FHA, as guarantors of the EMA Notes, pay such amount in damages in excess of $259,500 which consists of the principal amount of the EMA Notes, liquidated damages and default interest and (iii) that the Company pay reasonable legal fees incurred by EMA with respect to the prosecution of the lawsuit. The Company filed a Motion to Dismiss the complaint based on the criminal usury defense under New York law on January 18, 2018. EMA filed a Motion for Summary Judgment on the complaint on February 2, 2018. The Company cannot determine at this time whether the court will agree with the Company’s position, but the Company intends to litigate such allegations if a resolution cannot be agreed upon by the Company and EMA. The actions are still pending. See Note 8. – Convertible Notes Payable. On November 27, 2017, Auctus filed a complaint in the United States District Court, District of Massachusetts (Dkt. No. 1:17-cv-12329-LTS) against the Company. In the complaint, Auctus indicated that (i) on April 7, 2017, the Company and Auctus entered into a Securities Purchase Agreement (the “Auctus April 2017 SPA”) and the Company issued Auctus the “Auctus April Note” and (ii) on May 15, 2017, the Company and Auctus entered into an additional Securities Purchase Agreement (the “Auctus May 2017 SPA” and together with the Auctus April 2017 SPA, the “SPAs”) and the Company issued Auctus the “Auctus May Note”. In the complaint Auctus alleges the Company failed to apply at least 60% of the proceeds from financing transactions consummated during its second quarter ended September 30, 2017 towards the repayment of the Auctus May Note and the Company also failed to adhere to the prohibition of the Auctus May Note, which prohibited financing transactions by the Company for at least 90 days following the issuance of such note, without the prior written consent of Auctus, giving rise to an event of default. In addition, Auctus alleged a breach of the Auctus May Note resulted in a breach of the Auctus April Note by virtue of the cross-default provision contained in the Auctus April Note. Pursuant to the complaint, Auctus requests (i) that the Company pay such amount in damages in excess of $259,500 which consists of the principal amount of the Auctus Notes, liquidated damages and default interest and (ii) that the Company pay reasonable legal fees incurred by Auctus with respect to the prosecution of the lawsuit. At December 31, 2017, the Auctus Notes were disputed, contingent and unliquidated, and the Company intended to litigate such allegations if a resolution could not be agreed upon by all of the parties involved. At that time, it could not be determined whether the court would find the Auctus Notes in default as alleged in the Auctus compliant. In addition, the amount of any prejudgment cost, fees or penalties were not determinable and were not accrued for by the Company as of December 31, 2017. The Company recorded the Auctus Notes as a liability at its principal balance and continued to accrue interest as of December 31, 2017. The action was settled on January 24, 2018. See Note 8. – Convertible Notes Payable and Note 14. – Subsequent Events.

Subsequent Events

Subsequent Events	9 Months Ended
	Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	14. SUBSEQUENT EVENTS Convertible Promissory Notes Payable On January 29, 2018, the Company repaid the holder of the September 5 th On February 8, 2018, the holder of the August 3 rd On February 12, 2018, the holders of the August 14 th Convertible Note Payable – Auctus Settlement Agreement On January 24, 2018, the Company and Auctus entered into a Settlement Agreement and Mutual General Release (the “Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, among other things, the Company agreed to (i) initially register for resale on a registration to be filed with the Securities and Exchange Commission the (“SEC”) 1,500,000 shares (the “Registrable Securities”) of the Company’s common stock issuable upon conversion of the Auctus Notes and (ii) upon sale of all of the Registrable Securities, register for resale on a registration statement to be filed with the SEC such additional shares of the Company’s common stock to be issued to Auctus pursuant to the terms of the Settlement Agreement. In addition, if the Company files a registration statement with the SEC, Auctus shall have the right to request that the Company register shares of common stock underlying warrants issued to Auctus. The parties have agreed to release the other party together with its predecessors, parents, affiliates, subsidiaries, divisions, successors and assigns and the respective trustees, officers, directors, agents, representatives, employees, principals, shareholder, heirs, executors, administrators, attorneys and assigns from any and all liability actions, claims, damages, expenses or costs of whatever nature related to or arising out of the April 7, 2017 and May 15, 2017 Securities Purchase Agreement and the Auctus Notes. In addition, the parties have agreed to cause a Stipulation of Dismissal with Prejudice to be filed with respect to the action commenced by Auctus in the United States District Court for the District of Massachusetts (Dkt. No. 1:17-CV-12329-LTS). Common Stock During the period from January 1, 2018 through February 14, 2018, the Company sold an aggregate of 126,000 shares of common stock at $0.50 per share resulting in gross proceeds of $63,000. The Company also approved the issuance of an aggregate of 153,334 shares of common stock at $0.50 per share to individuals for services valued at $76,667. The shares of common shares sold and to be issued for services have not been issued as of February 14, 2018.

Summary of Significant Accoun20

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its subsidiaries, including Cannavoices, Inc. and FH Acquisition Corp. (“FHA”). All significant intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to amounts in prior periods to conform to the current period presentation. All reclassifications have been applied consistently to the periods presented. The reclassifications had no impact on net loss or total assets and liabilities.
Consolidated Variable Interest Entity ("VIE")	Consolidated Variable Interest Entity (“VIE”) On September 1, 2016, Cannavoices entered into a share exchange agreement with FHA, whereby all the issued and outstanding capital stock of FHA was exchanged for an aggregate of 1,334,262 shares of the Cannavoices’ common stock. FHA shares were exchanged on a one-for-one basis with the shares of the Cannavoices’ common stock. Effective on the date of the share exchange agreement, FHA became a wholly-owned subsidiary of the Company. The Company previously determined FHA was a VIE and Cannavoices was the primary beneficiary. This was concluded as FHA collected capital raised from investors and funded invoices of Cannavoices as directed by the Cannavoices’ Board of Directors. The Company has presented the financial statements on a consolidated basis since FHA’s inception (November 23, 2015). Accordingly, intercompany activity between the Company and FHA are eliminated in consolidation.
Use of Estimates	Use of Estimates The financial statements and accompanying notes are prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates and assumptions include the fair value of the Company’s stock and the valuation allowance relating to the Company’s deferred tax assets.
Revenue Recognition	Revenue Recognition In accordance with the Securities and Exchange Commission’s (“SEC”) Staff Accounting Bulletin (“SAB”) Topic 13, Revenue Recognition
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718 “Compensation – Stock Compensation” using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. The Company accounts for stock-based compensation to consultants and other third parties in accordance with ASC 505-50 “Equity-Based Payments to Non-Employees.” Compensation expense is determined at the “measurement date.” Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.
Dividends	Dividends The Company has not adopted any policy regarding payment of dividends. No dividends have been paid during any of the periods shown.
Advertising Costs	Advertising Costs The Company’s policy regarding advertising is to expense advertising when incurred. The Company did not incur any advertising expense for the three and nine months ended December 31, 2017 and December 31, 2016, respectively.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three months or less when purchased to be cash equivalents, to the extent the funds are not being held for investment purposes. As at December 31, 2017 and March 31, 2017, the Company had no cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts (if any) of cash, accounts payable, and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company measures the fair value of financial assets and liabilities based on the guidance of the FASB ASC in accordance with U.S. GAAP, ASC 820 “Fair Value Measurements and Disclosures”, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions)
Convertible Instruments	Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable ASC 480-10. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.
Derivative Financial Instruments	Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company’s own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company’s free-standing derivatives consisted of warrants to purchase common stock that were issued in connection with the issuance of debt and of embedded conversion options with convertible debentures. The Company evaluated these derivatives to assess their proper classification in the balance sheet as of December 31, 2017 using the applicable classification criteria enumerated under ASC 815-Derivatives and Hedging. The Company determined that certain embedded conversion and/or exercise features do not contain fixed settlement provisions. The convertible debentures contain a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the derivatives which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period.
Net Loss Per Common Share	Net Loss per Common Share Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Although there were common stock equivalents as of December 31, 2017, they were anti-dilutive. For the Three Months Ended For the Three Months Ended Net Loss $ (2,731,841 ) $ (475,793 ) Weighted Average Shares 30,326,520 23,223,187 Net Loss Per share $ (0.09 ) $ (0.02 ) For the Nine Months Ended For the Nine Months Ended Net Loss $ (9,494,826 ) $ (3,376,593 ) Weighted Average Shares 28,406,108 22,036,635 Net Loss Per share $ (0.33 ) $ (0.15 ) The following financial instruments were not included in the diluted loss per share calculation as of December 31, 2017 and 2016 because their effect was anti-dilutive: As of December 31 2017 2016 Warrants to purchase Common Stock $ 578,668 $ - Convertible notes 1,743,924 514,368 Total $ 2,322,592 $ 514,368
Income Taxes	Income Taxes The Company provides for income taxes under ASC 740 “Accounting for Income Taxes”. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. The Company classifies interest expense and any related penalties related to income tax uncertainties as a component of income tax expense. No interest or penalties have been recognized as of and for the quarters ended December 31, 2017 and 2016. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2017, the FASB issued Accounting Standards Update (“ASU”) No. 2017-12, Derivatives and Hedging, Targeted Improvements to Accounting for Hedging Activities. The amendments in ASU 2017-12 provided guidance to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results in the financial statements. The amendments expand and refine hedge accounting for both nonfinancial and financial risk components and align the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. For public business entities, the amendments in ASU 2017-12 are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. While the Company does not expect the adoption of ASU 2017-12 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2017-12 may have on its financial position, results of operations or cash flows. In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (“EPS”) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. While the Company does not expect the adoption of ASU 2017-11 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2017-11 may have on its financial position, results of operations or cash flows. In May 2017, FASB issued ASU 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting, which amends the scope of modification accounting surrounding share-based payment arrangements as issued in ASU 2016-09 by providing guidance on the various types of changes which would trigger modification accounting for share-based payment awards. ASU 2017-09 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods, which would be the Company’s fiscal year ending March 31, 2019. Early adoption is permitted, including adoption in any interim period, for public business entities for reporting periods for which financial statements have not yet been issued. While the Company does not expect the adoption of ASU 2017-09 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2017-09 may have on its financial position, results of operations or cash flows. In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, to improve and simplify the accounting for the income tax consequences of intra-entity transfers of assets other than inventory, requiring companies to recognize income tax consequences upon the transfer of the asset to a third party. ASU 2016-16 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods, which would be the Company’s fiscal year ending March 31, 2019. While the Company does not expect the adoption of ASU 2016-16 to have a material effect on its business, the Company is still evaluating any potential impact that adoption of ASU 2016-16 may have on its financial position, results of operations or cash flows. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, which will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The Company does not expect the adoption of ASU 2016-15 to have a material effect on its business, its financial position, results of operations or cash flows. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation – Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 simplifies the accounting for several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods, which would be the Company’s fiscal year ending March 31, 2018. The Company does not expect the adoption of ASU 2016-09 to have a material effect on its business, its financial position, results of operations or cash flows. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters into a lease, with some specified scope exemptions. The guidance in this update supersedes Topic 840, Leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For public companies, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, which would be the Company’s fiscal year ending March 31, 2020. The Company does not expect the adoption of ASU 2016-09 to have a material effect on its business, its financial position, results of operations or cash flows. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments and requires entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, and the separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (i.e., securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements. The guidance is effective for annual and interim reporting periods beginning after December 15, 2017. The Company expects that this guidance will not have a material effect on its financial statements. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,”, which requires entities to present deferred tax assets and deferred tax liabilities as noncurrent in a classified balance sheet. The ASU simplifies the current guidance in ASC 740, which requires entities to separately present deferred tax assets and liabilities as current and noncurrent in a classified balance sheet. ASU 2015-17 is effective for fiscal years beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for all entities as of the beginning of an interim or annual reporting period. The Company expects that this guidance will not have a material effect on its financial statements. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements—Going Concern,” which impacts the accounting guidance related to the evaluation of an entity’s ability to continue as a going concern. The amendment establishes management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern in connection with preparing financial statements for each annual and interim reporting period. The amendment also gives guidance to determine whether to disclose information about relevant conditions and events when there is substantial doubt about an entity’s ability to continue as a going concern. The amended guidance is effective prospectively for fiscal years beginning after December 15, 2016. The Company has adopted this new guidance effective as of the inception date. The adoption of this ASU did not have a material impact on the Company’s financial position, results of operations or cash flows. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) which amended the existing accounting standards for revenue recognition. ASU 2014-09 establishes principles for recognizing revenue upon the transfer of promised goods or services to customers, in an amount that reflects the expected consideration received in exchange for those goods or services. In July 2015, the FASB deferred the effective date for annual reporting periods beginning after December 15, 2017 (including interim reporting periods within those periods). Early adoption is permitted to the original effective date for annual reporting periods beginning after December 15, 2016 (including interim reporting periods within those periods). The amendments may be applied retrospectively to each prior period (full retrospective) or retrospectively with the cumulative effect recognized as of the date of initial application (modified retrospective). The Company will adopt ASU 2014-09 beginning April 1, 2018 and apply the full retrospective approach. Until such time as the Company makes an acquisition or commences monetizing its assets, the Company does not know what the impact of this new standard will be or if it will impact the Company’s disclosure.

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Schedule of Weighted Average Number of Shares	Although there were common stock equivalents as of December 31, 2017, they were anti-dilutive. For the Three Months Ended For the Three Months Ended Net Loss $ (2,731,841 ) $ (475,793 ) Weighted Average Shares 30,326,520 23,223,187 Net Loss Per share $ (0.09 ) $ (0.02 ) For the Nine Months Ended For the Nine Months Ended Net Loss $ (9,494,826 ) $ (3,376,593 ) Weighted Average Shares 28,406,108 22,036,635 Net Loss Per share $ (0.33 ) $ (0.15 )
Schedule of Anti-Dilutive Securities	The following financial instruments were not included in the diluted loss per share calculation as of December 31, 2017 and 2016 because their effect was anti-dilutive: As of December 31 2017 2016 Warrants to purchase Common Stock $ 578,668 $ - Convertible notes 1,743,924 514,368 Total $ 2,322,592 $ 514,368

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	9 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Schedule of Convertible Notes Payable	Convertible notes payable were comprised of the following as of December 31, 2017 and March 31, 2017: December 31, 2017 March 31, 2017 Auctus Fund LLC notes payable $ 259,500 $ - EMA Financial LLC 259,500 - Total notes payable 519,000 - Less unamortized debt discount (156,959 ) - Total notes payable net of unamortized debt discount 362,041 - Less current portion (362,041 ) - Long term portion $ - $ -

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	9 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Summary of Changes in Level 3 Financial Liabilities	The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of December 31, 2017: Warrant Liability Debt Derivative Balance, March 31, 2017 $ - $ - Total (gains) losses Initial fair value of debt derivative at note or warrant issuance 842,291 2,494,699 Mark-to-market at December 31, 2017: 1,640,428 (84,135 ) Balance, December 31, 2017 2,482,719 2,410,564 Net gain (loss) for the period included in earnings relating to the liabilities held at December 31, 2017 $ (1,640,428 ) $ (84,135 )

Nature of Business (Details Nar

Nature of Business (Details Narrative) - Cannavoices [Member]	Feb. 10, 2017shares
Number of common stock issued	23,267,231
Percentage of shares outstanding	97.70%

Going Concern and Management'25

Going Concern and Management's Plan (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 2,731,841	$ 475,793	$ 9,494,826	$ 3,376,593
Accumulated deficit	$ 16,557,211		$ 16,557,211		$ 7,062,385

Summary of Significant Accoun26

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Sep. 01, 2016	Dec. 31, 2017	Dec. 31, 2016
Interest or penalties
Cannavoices [Member] | Share Exchange Agreement [Member]
Exchanged share of common stock for issued and outstanding capital stock	1,334,262

Summary of Significant Accoun27

Summary of Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Accounting Policies [Abstract]
Net Loss	$ (2,731,841)	$ (475,793)	$ (9,494,826)	$ (3,376,593)
Weighted Average Shares	30,326,520	23,223,187	28,406,108	22,036,635
Net Loss Per share	$ (0.09)	$ (0.02)	$ (0.33)	$ (0.15)

Summary of Significant Accoun28

Summary of Significant Accounting Policies - Schedule of Anti-Dilutive Securities (Details) - shares	9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,322,592	514,368
Warrants To Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	578,668
Convertible Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,743,924	514,368

Convertible Promissory Note R29

Convertible Promissory Note Receivable (Details Narrative) - USD ($)	Oct. 20, 2017	Apr. 27, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2017
Receivables [Abstract]
Convertible promissory note, principal amount		$ 600,000	$ 100,000
Convertible note in cash consideration			$ 100,000
Convertible promissory note, interest rate		15.00%	6.00%
Convertible promissory note, maturity date	Oct. 31, 2019	Apr. 27, 2017	Nov. 30, 2017
Convertible promissory note receivable, including accrued interest				$ 110,500		$ 110,500		$ 106,000
Interest income				$ 1,500	$ 1,500	$ 4,500	$ 4,500

Asset Purchase Agreement - In30

Asset Purchase Agreement - Intellectual Property (Details Narrative) - USD ($)	Jul. 17, 2017	Jul. 17, 2017	Dec. 31, 2017	Dec. 31, 2016
Amortization expense			$ 305,023
Interactive Systems Worldwide, Inc. [Member]
Intangible assets fair value consideration		$ 2,000,000
IP assets term on straight-line basis		3 years
Interactive Systems Worldwide, Inc. [Member] | Restricted Stock [Member]
Aggregate restricted common stock issued	2,000,000
Number of common stock shares issued for purchase of assets	2,000,000
Shares issued price per share	$ 1	$ 1
Number of common stock shares issued for purchase of assets, value	$ 2,000,000

Note Payable (Details Narrative

Note Payable (Details Narrative) - USD ($)	Oct. 20, 2017	Apr. 27, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2017
Debt Disclosure [Abstract]
Debt instrument face amount		$ 600,000	$ 100,000
Note payable unamortized discount		$ 20,000		$ 0		$ 0		$ 1,667
Note payable, interest rate		15.00%	6.00%
Note payable, maturity date	Oct. 31, 2019	Apr. 27, 2017	Nov. 30, 2017
Note payable, extended maturity date		Jul. 1, 2017
Notes payable				600,000		600,000		$ 598,333
Interest expense				22,500	$ 62,500	62,500	$ 52,500
Amortization of debt discount				0	1,667	575,014	13,333
Accrued interest expense				$ 60,000	$ 0	$ 60,000	$ 0

Convertible Promissory Notes 32

Convertible Promissory Notes Payable (Details Narrative) - USD ($)	Dec. 13, 2017	Nov. 09, 2017	Oct. 20, 2017	Oct. 18, 2017	Oct. 11, 2017	Sep. 29, 2017	Sep. 05, 2017	Aug. 17, 2017	Aug. 14, 2017	Aug. 03, 2017	Jul. 18, 2017	Nov. 10, 2016	Apr. 27, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Oct. 05, 2017	Sep. 30, 2017
Accrued interest															$ 60,000	$ 0	$ 60,000	$ 0
Debt instrument, maturity date			Oct. 31, 2019										Apr. 27, 2017	Nov. 30, 2017
Convertible promissory note, interest rate													15.00%	6.00%
Debt instrument face amount													$ 600,000	$ 100,000
Interest expense															22,500	$ 62,500	62,500	$ 52,500
Debt fair value															$ 1,672,175		$ 1,672,175
Dividend yield percentage																	0.00%
Minimum [Member]
Volatility percentage																	228.13%
Weighted average risk-free interest rate																	0.44%
Expected lives years																	2 months 30 days
Estimated fair value common stock															$ 1		$ 1
Maximum [Member]
Volatility percentage																	260.33%
Weighted average risk-free interest rate																	1.35%
Expected lives years																	5 months 27 days
Estimated fair value common stock															$ 1.50		$ 1.50
Convertible Short-Term Promissory Notes [Member]
Convertible notes payable																				$ 6,250
Accrued interest				$ 1,260																$ 2,646
Debt instrument, maturity date	Mar. 13, 2018	May 9, 2018			Apr. 9, 2018	Mar. 28, 2018	Jan. 3, 2018	Aug. 17, 2018	Feb. 10, 2018	Jan. 30, 2018	Oct. 16, 2017	Oct. 5, 2017
Convertible promissory note, interest rate	10.00%	10.00%			10.00%	10.00%	10.00%	5.00%	10.00%	10.00%	10.00%	10.00%
Debt instrument face amount	$ 77,000	$ 15,000			$ 34,000	$ 10,000	$ 25,000	$ 300,000	$ 11,000	$ 20,000	$ 50,000
Number of common stock shares conversion of convertible note and accrued interest				51,260
Debt instrument, description	Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the December 13th Short-Term Note will be due and payable by the Company on the 90-day anniversary date of such note, or March 13, 2018.	Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the November 9th Short-Term Note will be due and payable by the Company on the 180-day anniversary date of such note, or May 9, 2018.			Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the October 11th Short-Term Notes will be due and payable by the Company on the 180-day anniversary date of such note, or April 9, 2018.	Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the September 29th Short-Term Note will be due and payable by the Company on the 180-day anniversary date of such note, or March 28, 2018.	Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the September 5th Short-Term Note will be due and payable by the Company on the 120-day anniversary date of such note, or January 3, 2018.	Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the August 17th Short-Term Note will be due and payable by the Company on the one-year anniversary date of such note, or August 17, 2018.	Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the August 14th Short-Term Notes will be due and payable by the Company on the 180-day anniversary date of the August 14th Short-Term Notes, or February 10, 2018.	Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the August 3rd Short-Term Note will be due and payable by the Company on the 180-day anniversary date of such note, or January 30, 2018.	The principal and accrued interest on the July Short-Term Notes became due and payable by the Company on the ninety-day anniversary date of the July Short-Term Notes, or October 16, 2017.
Conversion price	$ 1	$ 1			$ 1	$ 1	$ 1	$ 0.40	$ 1	$ 1
November Short Term Note [Member]
Convertible notes payable																			$ 6,250
Accrued interest																			$ 2,646
Debt instrument face amount															$ 0		$ 0
August Third Short-Term Promissory Notes [Member]
Accrued interest															822		822
Interest expense															504
August Fourteenth Short-Term Promissory Notes [Member]
Accrued interest															413		413
Interest expense															277
August Seventeenth Short-Term Promissory Notes [Member]
Accrued interest															9,411		9,411
Interest expense															7,562
September Fifth Short-Term Promissory Notes [Member]
Accrued interest															801		801
Interest expense															630
September Twenty Ninth Short-Term Promissory Notes [Member]
Accrued interest															255		255
Interest expense															252
October Eleventh Short-Term Promissory Notes [Member]
Accrued interest															857		857
Interest expense															857
Convertible Short-Term Promissory Notes One [Member]
Debt instrument, maturity date					Jan. 9, 2018
Convertible promissory note, interest rate					10.00%
Debt instrument face amount					$ 31,000
Debt instrument, description					Unless earlier converted into the Company’s common stock (as discussed below), the principal and accrued interest on the October 11th Short-Term Note will be due and payable by the Company on the 90-day anniversary date of such note, or January 9, 2018.
Conversion price					$ 1
October Eleventh Short-Term Promissory Notes One [Member]
Accrued interest															781		781
Interest expense															781
November Ninth Short-Term Promissory Notes [Member]
Accrued interest															378		378
Interest expense															378
December Thirteen Short-Term Promissory Notes [Member]
Accrued interest															357		$ 357
Interest expense															$ 357

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	Nov. 09, 2017	May 15, 2017	Apr. 07, 2017	Dec. 31, 2017	Dec. 31, 2017	Dec. 31, 2017	Dec. 31, 2016	Apr. 10, 2017	Mar. 31, 2017	Apr. 27, 2016	Mar. 31, 2016
Note payable, interest rate										15.00%	6.00%
Debt face amount										$ 600,000	$ 100,000
Warrant term						3 years
Exercise price per share				$ 5	$ 5	$ 5
Notes conversion percentage					100.00%
Warrant liability				$ 2,482,719	$ 2,482,719	$ 2,482,719
Dividend yield percentage						0.00%
Proceeds from convertible notes						$ 1,183,500	$ 438,000
Auctus May Note [Member]
Percentage of proceeds required towards payments of note						60.00%
Number of shares reserved for note conversion				2,445,000	2,445,000	2,445,000
Description on notice of default	The Company received a notice of default from Auctus with respect to the Auctus Notes, and Auctus commenced a lawsuit against the Company on November 27, 2017. Auctus alleged the Company failed to apply at least 60% of the proceeds from financing transactions consummated during its second quarter ended September 30, 2017 towards the repayment of the Auctus May Note and the Company also failed to adhere to the prohibition of the Auctus May Note, which prohibited financing transactions by the Company for at least 90 days following the issuance of such note, without prior written consent of Auctus, giving rise to an event of default. In addition, Auctus alleged a breach of the Auctus May Note resulted in a breach of the Auctus April Note by virtue of the cross-default provision contained in the Auctus April Note. At December 31, 2017, the Auctus Notes were disputed, contingent and unliquidated, and the Company intended to litigate such allegations if a resolution could not be agreed upon by all of the parties involved. At that time, it could not be determined whether the court would find the Auctus Notes in default as alleged in the Auctus compliant. In addition, the amount of any prejudgment cost, fees or penalties were not determinable and were not accrued for by the Company as of December 31, 2017. The Company has recorded the Auctus Notes as a liability at its principal balance and continued to accrue interest as of December 31, 2017. The parties entered into a settlement agreement on January 24, 2018.
Convertible Notes Financing [Member]
Warrants issued to purchase of shares				250,000	250,000	250,000
Debt derivative				$ 1,087,504	$ 1,087,504	$ 1,087,504
Warrant liability				2,482,719	2,482,719	$ 2,482,719
Dividend yield percentage						0.00%
Fair value derivatives and warrant liability				2,633,498	$ 2,633,498	$ 2,633,498
Proceeds from convertible notes						470,500
Interest expense						2,162,998
Debt discounts				$ 130,816		$ 362,041
Minimum [Member]
Volatility percentage						228.13%
Weighted average risk-free interest rate						0.44%
Expected lives years						2 months 30 days
Estimated fair value common stock				$ 1	$ 1	$ 1
Minimum [Member] | Convertible Notes Financing [Member]
Volatility percentage						234.00%
Weighted average risk-free interest rate						1.07%
Expected lives years						1 year
Estimated fair value common stock				$ 1.50	$ 1.50	$ 1.50
Maximum [Member]
Warrants issued to purchase of shares				328,668	328,668	328,668
Volatility percentage						260.33%
Weighted average risk-free interest rate						1.35%
Expected lives years						5 months 27 days
Estimated fair value common stock				$ 1.50	$ 1.50	$ 1.50
Maximum [Member] | Convertible Notes Financing [Member]
Warrants issued to purchase of shares				250,000	250,000	250,000
Volatility percentage						245.43%
Weighted average risk-free interest rate						1.92%
Expected lives years						5 years
Estimated fair value common stock				$ 3.74	$ 3.74	$ 3.74
Auctus Fund LLC [Member]
Note payable, interest rate				12.00%	12.00%	12.00%
Debt face amount		$ 84,500	$ 175,000	$ 259,500	$ 259,500	$ 259,500
Warrant term						5 years
Warrants issued to purchase of shares				125,000	125,000	125,000
Exercise price per share				$ 2	$ 2	$ 2
Default interest rate						24.00%
Notes due date						May 15, 2018
Debt conversion description						A 50% discount to the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading days prior to May 15, 2017 and (ii) 50% of the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading day period prior to conversion. The Auctus April Note is convertible into shares of the Company’s common stock at any time at a conversion price equal to the lesser of (i) a 60% discount to the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading days prior to April 7, 2017 and (ii) the 60% of the lesser of the lowest traded price and closing bid price of the common stock during the 25 trading day period prior to conversion.
Discount to lesser of the lowest traded price, percentage		50.00%	60.00%
Notes conversion percentage		50.00%	60.00%
Debt derivative				$ 502,590	$ 502,590	$ 502,590
Warrant liability				1,241,360	1,241,360	1,241,360
Auctus Fund LLC [Member] | Twenty Days Cure Period [Member]
Debt face amount				100,000	100,000	$ 100,000
Default interest rate						150.00%
Debt instrument periodic payment						$ 2,000
Auctus Fund LLC [Member] | Conversion Date [Member]
Beneficial ownership of outstanding common stock, percentage						4.99%
Auctus Fund LLC [Member] | Inception [Member]
Debt derivative				811,555	811,555	$ 811,555
Warrant liability				$ 423,011	$ 423,011	$ 423,011
EMA Financial LLC [Member]
Note payable, interest rate				12.00%	12.00%	12.00%
Debt face amount				$ 259,500	$ 259,500	$ 259,500
Warrant term						5 years
Warrants issued to purchase of shares				125,000	125,000	125,000
Exercise price per share				$ 2	$ 2	$ 2
Default interest rate						24.00%
Notes conversion percentage						50.00%
Number of shares reserved for note conversion				2,445,000	2,445,000	2,445,000
Proceeds from financing						$ 250,000
Debt derivative				$ 584,914	$ 584,914	584,914
Warrant liability				1,241,360	1,241,360	1,241,360
EMA Financial LLC [Member] | Twenty Days Cure Period [Member]
Debt face amount				50,000	50,000	$ 50,000
Default interest rate						150.00%
Debt instrument periodic payment						$ 1,000
Gross proceeds financing percentage						60.00%
EMA Financial LLC [Member] | Inception [Member]
Debt derivative				979,651	979,651	$ 979,651
Warrant liability				$ 419,280	$ 419,280	$ 419,280
EMA Financial LLC [Member] | Prepayment Termination Date [Member] | 25 Consecutive Trading Days [Member]
Beneficial ownership of outstanding common stock, percentage						4.99%
EMA Financial LLC [Member] | Minimum [Member]
Notes due date						Apr. 10, 2018
EMA Financial LLC [Member] | Maximum [Member]
Notes due date						May 15, 2018
EMA April Note [Member]
Debt face amount								$ 175,000
EMA April Note [Member] | 25 Consecutive Trading Days [Member]
Notes conversion percentage						60.00%
EMA April Note [Member] | Conversion Date [Member] | 25 Consecutive Trading Days [Member]
Notes conversion percentage						40.00%
EMA May Note [Member]
Debt face amount		$ 84,500
EMA May Note [Member] | 25 Consecutive Trading Days [Member]
Notes conversion percentage						50.00%
EMA May Note [Member] | Conversion Date [Member] | 25 Consecutive Trading Days [Member]
Notes conversion percentage						50.00%

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) - USD ($)	Dec. 31, 2017	Mar. 31, 2017
Less current portion	$ 600,000	$ 598,333
Convertible Notes Financing [Member]
Total notes payable	519,000
Less unamortized debt discount	(156,959)
Total notes payable net of unamortized debt discount	362,041
Less current portion	(362,041)
Long term portion
Convertible Notes Financing [Member] | Auctus Fund LLC [Member]
Total notes payable	259,500
Convertible Notes Financing [Member] | EMA Financial LLC [Member]
Total notes payable	$ 259,500

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative)	9 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares
Warrant term	3 years
Exercise price per share	$ 5
Dividend yield percentage	0.00%
Minimum [Member]
Volatility percentage	228.13%
Weighted average risk-free interest rate	0.44%
Expected lives years	2 months 30 days
Estimated fair value common stock	$ 1
Maximum [Member]
Warrants issued to purchase of shares | shares	328,668
Volatility percentage	260.33%
Weighted average risk-free interest rate	1.35%
Expected lives years	5 months 27 days
Estimated fair value common stock	$ 1.50
Warrant Liability [Member]
Warrant term	5 years
Warrants issued to purchase of shares | shares	250,000
Exercise price per share	$ 2
Fair value derivatives and warrant liability | $	$ 2,482,719
Dividend yield percentage	0.00%
Volatility percentage	235.92%
Weighted average risk-free interest rate	1.92%
Loss on change in warrant liabilities | $	$ 1,640,428
Warrant Liability [Member] | Minimum [Member]
Expected lives years	4 years 6 months 7 days
Warrant Liability [Member] | Maximum [Member]
Expected lives years	4 years 7 months 13 days
Convertible Notes [Member]
Fair value derivatives and warrant liability | $	$ 2,720,852
Dividend yield percentage	0.00%
Volatility percentage	299.88%
Loss on change in derivative liabilities | $	$ 84,135
Estimated fair value common stock	$ 2
Convertible Notes [Member] | Minimum [Member]
Weighted average risk-free interest rate	1.39%
Expected lives years	28 days
Convertible Notes [Member] | Maximum [Member]
Weighted average risk-free interest rate	1.53%
Expected lives years	7 months 13 days

Fair Value Measurement (Details

Fair Value Measurement (Details Narrative)	6 Months Ended
	Dec. 31, 2017USD ($)
Fair Value Disclosures [Abstract]
Derivative and warranty liabilities	$ 5,203,571
Stock price percentage	100.00%

Fair Value Measurement - Summar

Fair Value Measurement - Summary of Changes in Level 3 Financial Liabilities (Details)	9 Months Ended
	Dec. 31, 2017USD ($)
Warrant Liability [Member]
Derivative liability beginning balance
Total (gains) losses
Initial fair value of debt derivative at note or warrant issuance	842,291
Mark-to-market	1,640,428
Derivative liability ending balance	2,482,719
Net gain (loss) for the period included in earnings relating to the liabilities held at December 31, 2017	(1,640,428)
Debt Derivative [Member]
Derivative liability beginning balance
Total (gains) losses
Initial fair value of debt derivative at note or warrant issuance	2,494,699
Mark-to-market	(84,135)
Derivative liability ending balance	2,410,564
Net gain (loss) for the period included in earnings relating to the liabilities held at December 31, 2017	$ (84,135)

Stockholders' Equity and Cont38

Stockholders' Equity and Contributed Capital (Details Narrative) - USD ($)	Jul. 17, 2017	Dec. 31, 2017	Nov. 30, 2017	Oct. 31, 2017	Sep. 30, 2017	Aug. 31, 2017	Jul. 31, 2017	Jun. 30, 2017	May 31, 2017	Apr. 30, 2017	Dec. 31, 2017	Mar. 31, 2017
Common stock, shares authorized		500,000,000									500,000,000	500,000,000
Common stock, par value		$ 0.001									$ 0.001	$ 0.001
Preferred stock, authorized		10,000,000									10,000,000	10,000,000
Preferred stock, par value		$ 0.001									$ 0.001	$ 0.001
Common stock, shares issued		30,455,167									30,455,167	24,666,182
Common stock, shares outstanding		30,455,167									30,455,167	24,666,182
Preferred stock, shares issued		0									0	0
Preferred stock, shares outstanding		0									0	0
Number of common stock shares sold											164,334
Shares issued price per share		$ 1.50									$ 1.50
Stock options granted
Warrant exercise price per share		$ 5									$ 5
Warrant term											3 years
Convertible Notes Financing [Member]
Warrant to purchase share		250,000									250,000
Investor [Member]
Warrant exercise price per share		$ 2.50									$ 2.50
Warrant term											1 year
Common Stock [Member]
Number of common stock shares conversion of convertible note and accrued interest				51,260	128,084		266,667	30,838		67,653
Number of common stock conversion of convertible note and accrued interest				$ 51,260	$ 128,084		$ 200,000	$ 30,838		$ 50,740
Debt conversion price per share				$ 1	$ 1		$ 0.75	$ 1		$ 0.75
Number of shares exchanged for services provided		117,000		40,000	177,500	668,750	575,000
Number of shares exchanged for services provided, value		$ 117,000		$ 30,000	$ 266,250	$ 668,750	$ 575,000
Number of common stock shares sold		3,333	23,634	20,700	116,667		3,000	30,000	258,000
Value of common shares sold		$ 5,000	$ 33,450	$ 31,050	$ 175,000		$ 3,000	$ 30,000	$ 258,000
Shares issued price per share		$ 1	$ 1.50	$ 1.50	$ 1.50		$ 1	$ 1	$ 1		$ 1
Number of common stock shares issued for purchase of assets	2,000,000
Number of common stock shares issued for purchase of assets, value	$ 2,000,000
Common Stock [Member] | Individual [Member]
Number of shares exchanged for services provided									159,883
Number of shares exchanged for services provided, value									$ 159,883
Common Stock One [Member]
Number of common stock shares conversion of convertible note and accrued interest									21,559	120,957
Number of common stock conversion of convertible note and accrued interest									$ 21,599	$ 120,957
Debt conversion price per share									$ 1	$ 1
Number of common stock shares sold		4,000	2,000
Value of common shares sold		$ 4,000	$ 2,000
Shares issued price per share		$ 1	$ 1.50								$ 1
Common Stock Two [Member]
Number of shares exchanged for services provided										902,500
Number of shares exchanged for services provided, value										$ 902,500
Maximum [Member]
Common stock, shares authorized		500,000,000									500,000,000
Preferred stock, authorized		10,000,000									10,000,000
Warrant to purchase share		328,668									328,668
Maximum [Member] | Convertible Notes Financing [Member]
Warrant to purchase share		250,000									250,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Share based compensation	$ 44,842	$ 52,066	$ 244,073	$ 94,457
Development Agreement [Member]
Total value of certain development			2,000,000
Cannavoices [Member]
Rent expense		0		28,953
First Harvest Financial, Inc [Member]
Reimbursement of payments to management and subcontractors fees	8,005	16,000	36,880	164,600
Rent expense		23,500		51,359
The Great American Rolling Paper Company [Member]
Reimbursement of payments to management and subcontractors fees	0	26,573	0	57,515
First Harvest Corp [Member]
Reimbursement of payments to management and subcontractors fees			0	200
Lexington Tech Ventures Management, LLC [Member]
Reimbursement of payments to management and subcontractors fees			0	3,000
First Harvest Financial, Inc [Member]
Rent expense	15,000		45,000
HKA [Member]
Share based compensation	$ 0	$ 71,400	$ 199,000	$ 572,400

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	Nov. 27, 2017	Oct. 19, 2017	Dec. 31, 2017	Aug. 21, 2017	Jul. 01, 2017	May 15, 2017	Apr. 07, 2017	Apr. 27, 2016	Mar. 31, 2016
Debt instrument face amount								$ 600,000	$ 100,000
Hit Sum to Me, LLC [Member]
Debt instrument face amount				$ 600,000	$ 600,000
EMA Financial LLC [Member]
Debt instrument face amount			$ 259,500
EMA Financial LLC [Member] | Securities Purchase Agreement [Member]
Payment for damages		$ 259,500
Auctus Fund LLC [Member]
Debt instrument face amount			$ 259,500			$ 84,500	$ 175,000
Auctus Fund LLC [Member] | Securities Purchase Agreement [Member]
Payment for damages	$ 259,500
Description on notice of default	Auctus filed a complaint in the United States District Court, District of Massachusetts (Dkt. No. 1:17-cv-12329-LTS) against the Company. In the complaint, Auctus indicated that (i) on April 7, 2017, the Company and Auctus entered into a Securities Purchase Agreement (the “Auctus April 2017 SPA”) and the Company issued Auctus the “Auctus April Note” and (ii) on May 15, 2017, the Company and Auctus entered into an additional Securities Purchase Agreement (the “Auctus May 2017 SPA” and together with the Auctus April 2017 SPA, the “SPAs”) and the Company issued Auctus the “Auctus May Note”. In the complaint Auctus alleges the Company failed to apply at least 60% of the proceeds from financing transactions consummated during its second quarter ended September 30, 2017 towards the repayment of the Auctus May Note and the Company also failed to adhere to the prohibition of the Auctus May Note, which prohibited financing transactions by the Company for at least 90 days following the issuance of such note, without the prior written consent of Auctus, giving rise to an event of default. In addition, Auctus alleged a breach of the Auctus May Note resulted in a breach of the Auctus April Note by virtue of the cross-default provision contained in the Auctus April Note. Pursuant to the complaint, Auctus requests (i) that the Company pay such amount in damages in excess of $259,500 which consists of the principal amount of the Auctus Notes, liquidated damages and default interest and (ii) that the Company pay reasonable legal fees incurred by Auctus with respect to the prosecution of the lawsuit. At December 31, 2017, the Auctus Notes were disputed, contingent and unliquidated, and the Company intended to litigate such allegations if a resolution could not be agreed upon by all of the parties involved. At that time, it could not be determined whether the court would find the Auctus Notes in default as alleged in the Auctus compliant. In addition, the amount of any prejudgment cost, fees or penalties were not determinable and were not accrued for by the Company as of December 31, 2017. The Company recorded the Auctus Notes as a liability at its principal balance and continued to accrue interest as of December 31, 2017. The action was settled on January 24, 2018.

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Feb. 12, 2018	Feb. 08, 2018	Jan. 24, 2018	Feb. 14, 2018	Dec. 31, 2017	Jan. 29, 2018	Apr. 27, 2016	Mar. 31, 2016
Debt face amount							$ 600,000	$ 100,000
Number of shares sold during period					164,334
Stock sold price per share					$ 1.50
Subsequent Event [Member]
Number of shares sold during period				126,000
Stock sold price per share				$ 0.50
Gross proceeds from stock sold				$ 63,000
Number of shares issued for services provided				153,334
Shares issued, price per share				$ 0.50
Number of shares issued for services provided, value				$ 76,667
Subsequent Event [Member] | Settlement Agreement [Member] | Auctus Note [Member]
Number of common stock shares conversion of debt			1,500,000
Subsequent Event [Member] | September 5th Short-Term Note [Member]
Debt face amount						$ 25,000
Accrued interest						$ 979
Notes payable				0
Subsequent Event [Member] | August 3rd Short-Term Note [Member]
Debt face amount		$ 20,000
Accrued interest		$ 1,036
Notes payable				0
Number of shares sold during period		42,072
Stock sold price per share		$ 0.50
Subsequent Event [Member] | August 14th Short-Term Note [Member]
Debt face amount	$ 11,000
Accrued interest	$ 543
Notes payable				$ 0
Number of common stock shares conversion of debt	23,086
Debt conversion price per share	$ 0.50